D. Boucher et al., Screening for cystic fibrosis transmembrane conductance regulator gene mutations in men included in an intracytoplasmic sperm injection programme, MOL HUM REP, 5(6), 1999, pp. 587-593
The present study was undertaken to evaluate the frequency and nature of mu
tations in the cystic fibrosis transmembrane conductance regulator (CFTR) g
ene in infertile patients undergoing intracytoplasmic sperm injection. A to
tal of 90 patients were screened for a panel of 10 mutations in the CFTR ge
ne frequently involved in congenital absence of the vas deferens (CAVD); th
e patients included 14 with azoospermia and CAVD, 39 patients with azoosper
mia without CAVD (n = 39) and 37 patients with severe oligozoospermia. The
length of the polymorphic polypyrimidine tract (allele 5T, 7T and 9T) in th
e intron 8/exon 9 splice-acceptor site was also determined. In 10 out of 14
patients with CAVD, CFTR mutations were found; nine patients had one Delta
F508 mutation and one patient had two CFTR mutations (N1303K/R117H). Allel
e 5T was present in eight of these patients. In six patients, 5T was the no
n-Delta F508 allele and in two patients there was no known CFTR mutation. N
one of the CFTR mutations were observed in patients with azoospermia withou
t CAVD or with severe oligozoospermia and the frequency of allele 5T was 3.
6% (three out of 78 alleles) and 1.35% tone out of 74 alleles) respectively
. Our observation suggests that the CFTR gene is not involved in either spe
rmatogenesis or in the pathology of the genital tract, except for CAVD.